Investor Lux Ventures II, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Lux Ventures II, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2021-02-01 13D/A MRAM / Everspin Technologies, Inc. 1,015,550 0
2017-02-08 13D MRAM / Everspin Technologies, Inc. 1,015,550
2016-02-16 13G/A GNCA / Genocea Biosciences Inc 175,273
2015-02-13 13G GNCA / Genocea Biosciences Inc 1,072,611
2015-02-13 13G/A DARE / Daré Bioscience, Inc. 911,316
2014-04-18 13G DARE / Daré Bioscience, Inc. 951,999